{"nct_id":"NCT00191971","title":"2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen","status":"COMPLETED","status_verified_date":"2007-11","start_date":"2004-01","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2006-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["LLY"]}